A polymorphism of TM6SF2 associates with hepatic lipid accumulation and reduction of triacylglycerol (TAG) secretion, but the function of the encoded protein has remained enigmatic. We studied the effect of stable TM6SF2 knock-down on the lipid content and composition, mitochondrial fatty acid oxidation and organelle structure of HuH7 hepatoma cells. Knock-down of TM6SF2 resulted in intracellular accumulation of TAGs, cholesterol esters, phosphatidylcholine (PC) and phosphatidylethanolamine. In all of these lipid classes, polyunsaturated lipid species were significantly reduced while saturated and monounsaturated species increased their proportions. The PCs encountered relative and absolute arachidonic acid (AA, 20:4n-6) depletion, and AA was also reduced in the total cellular fatty acid pool. Synthesis and turnover of the hepatocellular glycerolipids was enhanced. The TM6SF2 knock-down cells secreted lipoprotein-like particles with a smaller diameter than in the controls, and more lysosome/endosome structures appeared in the knock-down cells. The mitochondrial capacity for palmitate oxidation was significantly reduced. These observations provide novel clues to TM6SF2 function and raise altered mebrane lipid composition and dynamics among the mechanism(s) by which the protein deficiency disturbs hepatic TAG secretion.
Introduction
Non-alcoholic fatty liver disease (NAFLD) with a global prevelance of 25 to 30% ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis, and can progress into hepatocellular carcinoma [1] . Genetic variants of patatin-like phospholipase domain containing 3, PNPLA3 (rs738409 and rs2281135), transmembrane 6 superfamily member 2, TM6SF2 (rs58542926) and membrane bound Oacyltransferase domain containing 7, MBOAT7 (rs641738) are associated with the development of NAFLD [2] [3] [4] .
The allelic frequency of the TM6SF2 variant is 7% and the carriers have increased susceptibility to NAFLD [3] but are protected from cardiovascular diseases [5] . TM6SF2 is predominantly expressed in liver, small intestine and kidney. It encodes a protein of 351 amino acids with 7-10 predicted transmembrane domains. The variant TM6SF2 encodes lysine instead of glutamine at position 167 of the protein (Glu167Lys). This substitution decreases the stability of the TM6SF2 protein [3] . TM6SF2 knock-down in mouse liver elevated the levels of hepatic cholesterol and triacylglycerols (TAGs), while verylow-density lipoprotein (VLDL) secretion was found to be reduced and the animals displayed reduced plasma cholesterol and TAG concentrations [3, 5] . Consistently, hepatic TM6SF2 overexpression led to increased levels of hepatic total cholesterol and plasma low-density lipoprotein (LDL) cholesterol [6] . Recently, Smagris et al. [7] reported that the decrease of plasma TAGs in TM6SF2 knock-out mice is not due to reduced VLDL secretion but decreased lipidation of the VLDL particles.
The TM6SF2 protein is localized in the endoplasmic reticulum (ER) and the Golgi complex of hepatocytes [7, 8] , where the assembly and lipidation of VLDL particles takes place. Thus, the observed instability of the variant TM6SF2 protein [3] may disturb the lipidation of VLDL particles. The membrane contents of polyunsaturated fatty acids (PUFAs), especially arachidonic acid (20:4n-6, AA), have recently been implicated in efficient clustering of TAGs for lipoprotein transport [9] . However, in TM6SF2 knock-out mice no major differences were found in the level of hepatic phosphatidylcholines (PCs) or in their fatty acid (FA) composition [7] . The knock-out mouse model of Fan et al. [6] rather implicated a predominant role of TM6SF2 in cholesterol metabolism. Thus, the mechanism of TM6SF2 function is unknown and the cause of increased hepatic lipid content in carriers of the variant allele is not understood.
In this study, we analyzed in vitro the effect of TM6SF2 on hepatocyte lipid content and lipid species composition using the human hepatocyte cell line HuH7 subjected to knock-down of TM6SF2. Pulse chase experiments with [ 13 C]glycerol were performed to investigate the turnover rates of different lipids. To investigate the functional consequences of the lipid alterations, we studied the rates of mitochondrial oxygen consumption (OCR) with FA as substrate, in the control and TM6SF2 knock-down cells. In addition, electron and fluorescence microscopy were employed to observe possible differences in organelle structure or distribution between the TM6SF2 deficient and control cells. The hallmark observations in the TM6SF2 knock-down cells were an enrichment of saturated (SFAs) and monounsaturated FAs (MUFAs) in storage and membrane lipids, a depletion of AA in PCs, and functional changes indicated by a reduced mitochondrial OCR with FA as substrate, an increase in the number of lysosome/endosome structures as compared to controls, and reduced size of secreted lipoprotein-like particles. These observations provide novel clues to the TM6SF2 function and suggest that an altered membrane lipid composition and dynamics play roles in the mechanism(s) by which the protein deficiency disturbs hepatic TAG secretion.
Materials and methods

Cell culture and generation of HuH7 hepatocytes with TM6SF2 stably knocked down
TM6SF2 knock-down HuH7 hepatocytes were generated using a lentiviral transduction approach. Briefly, HuH7 cells were cultured in MEM AQ™ (Minimal essential Eagle medium; Sigma-Aldrich, St. Louis, MO) with 10% FBS (fetal bovine serum), 100 μg/ml streptomycin and 100 U/ml penicillin. Cells were grown to 70% confluency and transduced with lentiviral particles encoding shRNA against TM6SF2 (TRCN0000254085, Sigma-Aldrich) or a non-targeting control (SHC002V), according to the manufacturer's protocol. Transduced cells were selected with puromycin (5 μg/ml). The selected cells were grown further in the above medium containing puromycin and used for further experiments. The experiments were performed using two independent biological replicates.
Gene expression analysis (qPCR)
Expression of TM6SF2 gene was analyzed by quantitative polymerase chain reaction (qPCR) by using Light Cycler 480 II (Roche Applied Science, Penzberg, Germany). Total RNA was extracted from the TM6SF2 knock-down and control HuH7 cells using PureLink® RNA Mini Kit according to the manufacturer's protocol. cDNA synthesis was carried out using SuperScript® VILO™ reverse transcriptase kit (Invitrogen, Carlsbad, CA). Quantitative real time PCR was performed with gene-specific primers (Table S1 ) and Roche SYBR-Green® master mix. SDHA (Succinate dehydrogenase complex, subunit A) and β-actin were used as housekeeping references, and the data were normalized to a geometric mean of these.
Lipid labeling and analysis by mass spectrometry and gas chromatography
For lipidomics, HuH7 cells cultured on 6-well plates as specified above were washed with PBS and scraped into 1 ml of ice-cold 0.25 M sucrose. For analysis of lipid turnover, the medium of the cells on 6-well plates was on the day one after plating changed to a labeling medium containing 500 μg/ml of [
13 C]glycerol (Cambridge Isotope Laboratories, Andover, MA). The cells were first incubated for 24 h and then chased for another 24 h in medium containing 5 mg/ml of unlabeled glycerol. Cellular lipids were extracted according to Folch et al. [10] and dissolved in chloroform/methanol 1:2 (by vol). Just before mass spectrometry, 1% NH 4 OH was added along with a cocktail of internal lipid standards containing respresentatives for all lipid classes analyzed. The samples were injected into the electrospray source of a triple quadrupole mass spectrometer (Agilent 6490 Triple Quad LC/MS with iFunnel Technology; Agilent Technologies, Santa Clara, CA) at a flow rate of 10 μl/min, and spectra were recorded using both positive and negative ionization mode. TAGs were detected as (M + NH 4 ) + ions [11] and cholesterol esters (CEs) using precursor ion scanning of m/z 369 (P369) in the positive ion mode [12] . Phospholipid species were selectively detected using head-group specific MS/MS scanning modes (PC: P184, PE: neutral loss of 141 (NL141), PI: P241) [13] . The unlabeled [M] and [
ions were resolved by comparing the spectra of cell samples with or without labeling, and deconvolution into different species was performed by the best profile fitting available in LIMSA software [14] . FA composition of total lipids was determined by gas chromatography (quantitation by Shimadzu GC-2010 Plus equipment with flame-ionization detector, GC-FID, and identification of FA structures by Shimadzu GCMSQP2010 Ultra with mass selective detector, GC-MSD) using procedures detailed in Käkelä et al. [15] . In order to confirm the glycerolipid acyl chain assembly, precursor scans for the main acyl chains, first detected by GC, were recorded by ESI-MS/MS using negative mode precursor scans for the acyl fragments released from PEs and PC formate adducts. The acyl chains of the TAGs were verified by positive mode ESI-MS/MS using acyl chain specific NL scans. Mass spectra were processed by MassHunter software (Agilent Technologies, Inc. California, USA) and individual lipid species were quantified using the internal standards and LIMSA software.
Analysis of de novo lipogenesis
HuH7 control and TM6SF2 knock-down cells were grown on 6- 
Glucose uptake assay
Glucose uptake assay was done in HuH7 control and TM6SF2 knockdown cells, which were starved in serum free, glucose free DMEM (A14430-01, Thermo Scientific) for one hour, after which glucose uptake was initiated by the addition of 0.5 ml DMEM with 100 μM cold D-glucose and 0.1 μCi of deoxy-D-glucose 2- [1, [2] [3] H (N)] (Perkin Elmer). The uptake was terminated by removing the media and adding ice cold PBS. The cells were washed and then lysed with 0.1% sodium dodecyl sulfate (SDS). The radioactivity in the cells was measured by liquid scintillation counting. The radioactive counts were normalized to total protein.
Glycogen synthesis assay
HuH7 control and TM6SF2 knock-down cells were grown on 6-well plates to confluency. The cells were starved overnight in DMEM (D5546, Sigma-Aldrich) containing 0.5% BSA and 2 mM L-glutamine. Next day the cells were incubated in 0.18 μCi/μmol D-[U-
14 C]-glucose (PerkinElmer) for 1 or 4 h, washed with ice cold PBS and frozen overnight in − 20°C. Samples were lysed in 0.7 ml 0.03% SDS and 0.4 ml of the suspension was transferred to 2 ml tubes together with 1 mg carrier glycogen. The remaining cell suspension was used for protein concentration determination by the bicinchoninic acid (BCA) assay (Thermo Scientific, Waltham, MA). The original samples were heated in 100°C for 30 min. Glycogen was precipitated by addition of 99% ethanol and incubated overnight in −20°C. Glycogen pellets were collected by centrifugation for 15 min at 10000 rpm, washed once with 70% ethanol and resuspended in 200 ml distilled water. Radioactivity was determined by liquid scintillation counting. Each experiment was carried out on triplicate wells.
Analysis of mitocondrial oxygen consumption rate (OCR)
The OCR of control and TM6SF2 knock-down cells was measured using the Seahorse XF96 Extracellular Flux Analyzer (Agilent Technologies). Both control and TM6SF2 knock-down HuH7 cells were plated onto Poly-L-Lysine coated XF96 cell culture micro plates (Agilent Technologies). Cells were grown until confluency in growth medium, followed by a serum starvation for 4 h in XF base medium (Agilent Technologies) supplemented with 0.5 mM glucose, 1 mM glutamine and 0.5 mM carnitine. Cells were then moved to a CO 2 free incubator and incubated for another 1 h in XF base medium supplemented with 0.5 mM glucose and 0.5 mM carnitine, after which cells were treated with 0.17 mM FA free BSA or 0.16 mM palmitic acid (Sigma-Aldrich) conjugated with FA free BSA, and incubated for an additional 1 h. The OCR was measured using the XF Cell Mito Stress Test Kit (Agilent Technologies) with following additions: oligomycin (0.6 μM), FCCP (0.5 μM), and rotenone (0.5 μM) plus antimycin A (0.5 μM). Three 3-min cycles were measured for each condition and the OCR were normalized to total protein content of each well determined by the BCA assay. The basal respiration due to utilization of exogenous FAs was calculated according to the manufacturer's protocol (basal palmitate-BSA rate minus basal BSA rate minus OCR due to uncoupling by free FAs).
Electron microscopy (EM) of cells
The cells were grown on glass cover slips for flat embedding, while normal cell culture dishes were used for pellet embedding. For flat embedding, the cells were fixed in 2% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4, for 30 min at room temperature. For pelleting, cells were fixed in 2% glutaraldehyde in 0.2 M Hepes, pH 7.4, at room temperature for 2 h. The cells were then scraped off the dish after 30-min fixation, pelleted with a microcentrifuge in the fixative, and the fixation was continued as a pellet. The fixed cells and cell pellets were then washed, post-fixed in 1% osmium tetroxide, dehydrated in ethanol and acetone, and embedded in TAAB resin. Thin sections were cut using a diamond knife and stained with uranyl acetate and lead citrate.
Pelleted cells were used for quantification of cytoplasmic volume fractions due to the random orientation of cells in relation to the section plane in such specimens. Micrographs were taken using uniform random sampling at 2000× primary magnification, using a Jeol JEM-1400 transmission electron microscope. A total of 65-70 micrographs for each sample were used for the quantification. The area of the cytoplasm and the organelles was quantified using point counting as detailed in [17] . The ratio of the organelle area per cytoplasmic area was used as an estimate for the volume fraction.
Immunofluorescence microscopy
TM6SF2 knock-down and control HuH7 cells on coverslips were fixed with 4% paraformaldehyde in PBS and permeabilised using 0.1% Triton X-100. Cells were then washed twice with PBS and unspecific antibody binding was blocked with 10% FBS, followed by incubation with anti-LAMP1 (H4A3, Santa Cruz biotechnology) for 2 h at room temperature. Cells were then washed thrice using PBS and incubated with Alexa Fluor®488-Anti-mouse (A11001, Invitrogen Life Sciences). After washing thrice the coverslips were mounted using Mowiol (Calbiochem, La Jolla, CA) containing 50 mg/ml 1,4-Diazabicyclo-[2.2.2] octane (Sigma-Aldrich) and 5 μg/ml DAPI (Thermo Scientific/ Molecular Probes). Cells were imaged using Zeiss Axio Observer Z1 microscope (Carl Zeiss Imaging Solutions GmbH, Oberkochen, Germany) with an objective of 63× magnification and numerical aperture 1.4 and Colibri laser and with same exposure time for both control and knock-down cells. LAMP1 stainings were quantified using FIJI (Image J) software with a set cutoff threshold (total signal intensity/number of cells in the field). Approximately 100 cells were measured in both TM6SF2 knock-down and control specimens.
EM of secreted lipoprotein-like particles
HuH7 control and TM6SF2 knock-down cells were grown in 75 cm 3 flasks to confluency, after which media samples were collected and concentrated using Spectra/Por® 4 dialysis tubing (Spectrum Laboratories, Inc., California, USA) against crystal sucrose and then dialyzed against PBS. The samples were centrifuged, pipetted on formwar-coated, glow discharged grids and negative stained using 1% phosphotungstic acid. Micrographs were taken using a Jeol JEM-1400 transmission electron microscope. Electron micrographs were processed using ImageJ open platform image processing program to analyze secreted particles. A median filter was first applied using a kernel of a radius of 5-pixels, then the images were automatically thresholded using the percentile method. Thresholded images were used to detect regions with an area between 1000 and 3000 pixels square and a circularity value of at least 0.3. This method allowed reliable automated detection of secreted particles within the defined range. The Pixel value was converted to nm 2 and the diameter of the particles were calculated.
Quantification of apolipoprotein B100 secretion
HuH7 control and TM6SF2 knock-down cells grown on 12-well plates were kept overnight in MEM AQ TM containing 100 μg/ml streptomycin and 100 U/ml penicillin, and the following day the media were collected, centrifuged and stored at −20°C. The cells were lysed and used for protein concentration determination by the BCA assay. The media were analyzed using Human Apolipoprotein B ELISA PRO kit (3715-1HP-2, Mabtech, Sweden) according to the manufacturer's protocol. The absorbance was measured at 450 nm in a microplate reader and a 4-parameter curve fitting program was used for data analysis.
Statistical analysis
For univariate comparisons statistical significance was determined by a two-tailed Student's t-test. For multivariate comparisons of detailed lipid profiles, Principal Component Analysis (PCA) (Sirius, PRS, Bergen, Norway) was used. The PCA shows compositional differences between the samples, and highlights the lipid species mainly responsible for the variation in the data. For PCA, arcsine transformed data were used and the relative positions of the samples and variables were plotted using the first two principal components. The differences between the groups seen in the PCA were further quantitatively analyzed using Soft Independent Modeling of Class Analogy (SIMCA; Sirius) [18] .
Results
Triacylglycerol and cholesterol ester concentrations are increased in HuH7 hepatocytes with TM6SF2 stably knocked down
HuH7 cells were subjected to stable knock-down of TM6SF2 using a shRNA expressing lentivirus. To avoid biases caused by phenotypic aberrations frequently occurring in single-cell clones, pools of transduced cells were analyzed. In such pools, an average knock-down efficiency of 60% at the mRNA level was observed as compared to controls transduced with a non-targeting shRNA lentivirus (Fig. 1A) . Upon mass spectrometric analysis of the cellular lipids, significant elevations of total TAG (32%) and CE (41%) concentrations were observed in the TM6SF2 knock-down cells (Fig. 1B-C) , consistent with previously published reports [3, 8] .
3.2. TM6SF2 silenced cells are relatively depleted of PUFA containing lipids and enriched in SFA and MUFA containing lipids Lipid species profiles of the control and TM6SF2 knock-down cells were subjected to PCA to reveal lipidome differences between the cell pools ( Fig. 2A-D) (The full lipid species data are shown in Tables S2-6 ). The most important principal component PC1 (horizontal axes) represented the degree of unsaturation of the lipid species, and explained 60% (TAG), 64% (CE), 88% (PC) or 93% (PE) of the variation in the lipid classes displayed ( Fig. 2A-D) . When focusing on TAG composition, the control cells grouped on the left-hand side of the PCA biplot i.e. they contained more TAGs with PUFA moieties (e.g. TAG species 56:6, 56:7, 58:7, and 58:8) whereas the TM6SF2 knock-down cells grouped on the right-hand side, and were characterized by TAGs with SFAs and MUFAs ( Fig. 2A) . The difference in the TAG species profiles of the control and TM6SF2 knock-down was significant according to SIMCA (p < 0.05).
When CE species were used as loadings, PCA indicated a similar loss of unsaturated acyl chains in TM6SF2 knock-down cells as was found for the TAGs (Fig. 2B) . The most divergent CE species variable, located furthest from the origin, was CE 22:6 (CE with docosahexaenoic acid, or DHA, moiety). In general, TM6SF2 knock-down cells (5 out of 6 replicates) contained smaller relative amounts of CE 22:6 and at the same time more of SFA and MUFA containing CEs as compared to the controls.
For the major membrane phospholipids of the cells, PCs and PEs, the PCA separation by PC1 (acyl chain unsaturation) was very clear (Fig. 2C-D) and quantitatively significant (SIMCA, p < 0.05). Of note, this change in the PC and PE species composition was accompanied by an increase in the total level of cellular PCs and PEs in the TM6SF2 knock-down cells as compared to controls (inserts, Fig. 2C-D) . Similar to the TAGs and CEs, the TM6SF2 knock-down cells contained higher relative amounts of PC and PE species carrying SFAs and MUFAs and less species with PUFA chains, especially AA (e.g. 36:4, 38:4, and 38:5, the presence of AA verified upon fragmentation by ESI-MS/MS). This suggests that there is a global shift in the lipid species profile of the TM6SF2 knock-down cells. Furthermore, when the FA composition in the total lipids of the cells after 24 h culture was investigated by gas chromatography, the total level of AA was found to be significantly lower (p < 0.01) in the TM6SF2 knock-down cells as compared to controls (Table S7 ).
Absolute levels of AA containing PCs are decreased in TM6SF2 knockdown cells
In order to clarify whether the changes observed in the phospholipid species composition of the TM6SF2 knock-down cells were due to increase in the levels of SFA/MUFAs containing species or decrease of PUFA (especially AA) containing species, or possibly both, we calculated the absolute levels of these lipids by normalizing them to total cellular protein. In PCs, but not in any other phospholipid class analyzed (PEs and PIs), the absolute levels of AA containing species 36:4 and 38:5 were in 24-h cultures significantly lower in TM6SF2 knock-down cells as compared to controls (Fig. 3A) . After extended (one week) culture time also the difference in PC 38:4 became significant (Fig. 3B) . When looking at the levels of SFA/MUFA containing lipids, significant increases in the absolute levels of PC 34:2, 36:1 and 36:2 at the 24-h time point and PC 34:1, 36:1 and 36:2 at the one week time point were observed in the TM6SF2 knock-down cells as compared to controls (Fig. 3A-B) . Comparison of the 24-h and one week culture times revealed that, overall, the differences in the lipid levels between the cell pools became more pronounced over the time. (Fig. 4A-D) . However, during 24-h chase in a medium containing unlabeled glycerol, the amount of the labeled lipids also reduced more rapidly in the TM6SF2 knock-down cells as compared to controls (turnover rates are indicated by the slopes visualized in the panels of Fig. 4) . Consistent with the enhanced incorporation of [
Glycerolipid turnover is enhanced in TM6SF2 knock-down cells
13 C]glycerol into TAGs, we also observed an elevation (Fig. S1 ). However, glucose uptake or glycogen synthesis were not affected (Fig. S2) .
TM6SF2 knock-down cells secrete smaller lipoprotein-like particles
We next wanted to see if changes in the lipid profile of the cells associate with an altered secretion of lipoproteins. We performed EM of particles secreted into growth media of control and TM6SF2 knockdown cells. While large, spherical lipoprotein-like particles were prominently present in the medium of control cells, the size of the particles secreted by TM6SF2 knock-down cells was markedly smaller (Fig. 5A) . The relative particle size distribution of the cells (Fig. 5B) revealed that particles > 20 nm in diameter were nearly undetectable in the medium of TM6SF2 knock-down cells. However, apolipoprotein B100 secretion was not reduced but rather slightly increased in the TM6SF2 knock-down cells (Fig. 5C ).
TM6SF2 knock-down cells display a reduced rate of mitochondrial fatty acid oxidation
Mitochondrial β-oxidation was measured by the mitochondrial oxygen consumption rate (OCR) in TM6SF2 knock-down and control cells, using palmitic acid (16:0) as substrate. The result of a mitochondrial stress test experiment carried out with the Seahorse® metabolic flux analyzer is presented in Fig. 6 . The measurements showed that the basal OCR in the presence of palmitic acid was higher in control cells than in the TM6SF2 knock-down cells (Fig. 6A-B) . Both TM6SF2 knockdown and control cells responded to the addition of the ATP-synthase inhibitor oligomycin by a decrease in the OCR (Fig. 6A) . Subsequent addition of the uncoupler FCCP lead to a rapid activation of the OCR in both TM6SF2 knock-down and control cells (Fig. 6A) . These finding indicate that TM6SF2 knock-down lead to a decreased basal OCR, while the mechanisms coupling ATP production to oxygen consumption remained unaffected, suggesting that TM6SF2 knock-down selectively acted on some component(s) required for β-oxidation. Quantitative analysis yielded that TM6SF2 knock-down lead to a 63% drop in the basal palmitate-driven OCR, compared to control cells (Fig. 6B) . 
Expansion of late endosome/lysosome structures in TM6SF2 knockdown hepatocytes
A significant increase in the absolute cellular concentrations (per total cell protein) of the major classes of membrane phospholipids, PCs and PEs, was observed in the TM6SF2 knock-down hepatocytes (see Fig. 2C-D) . We therefore carried out EM in order to detect possible differences in organelle structure of the cells. An increased number of late endosomes/lysosomes was evident in the sections of TM6SF2 knock-down cells as compared to controls. Quantification of the volume fraction of late endosomes/lysosomes in the cytoplasmic compartment of these cells revealed a 2.9-fold increase relative to the controls (Fig. 7A) . To further confirm this observation, we performed immunofluorescence microscopy with antibodies against the lysosome marker LAMP1. The LAMP1 staining intensity was 2-fold higher in the TM6SF2 knock-down cells than in the controls (Fig. 7B) , consistent with an amplification of the late endosomal/lysosomal compartments.
Discussion
TM6SF2 is a novel key regulator of hepatic VLDL TAG secretion. Its common sequence variant reducing the stability of the encoded protein [3] associates with hepatic TAG accumulation but acts protective against cardiovascular diseases [5, 19] . However, the molecular mechanisms of TM6SF2 function have remained enigmatic. In the present study we knocked down TM6SF2 by 60% in the human HuH7 hepatoma cell line, which has been employed in previous investigations as a hepatocyte model to assess the function of TM6SF2 [3, 8] . Mass spectrometric analysis of the cellular lipidome and its dynamics, measurements of mitochondrial oxygen consumption rate and studies of organelle structure revealed that TM6SF2 knock-down results in ( It is becoming evident that the hepatic lipid composition plays a major role in lipoprotein secretion, lipid accumulation and pathology. The excess SFAs and MUFAs found in this work in the TM6SF2 knockdown cells, have been reported to have deleterious effects on liver function and cause tissue damage [20] . In our cell model, the accumulation of SFAs and MUFAs could be due to the elevated de novo lipogenesis utilizing these acyl chains, or occur through other mechanisms such as enhanced SCD1 activity in the knock-down cells. Stearoyl desaturase 1 (SCD1, Δ-9 desaturase) activity was found to increase in fatty liver diseases, leading to the accumulation of MUFAs [21] , and inhibition of SCD1 reduced the induction of hepatic steatosis in mouse models [22] . On the other hand, increased SCD1 activity was also suggested to have a protective effect against hepatic injury. SCD1 converts SFAs to MUFAs, enhances the incorporation of MUFAs to TAGs, and protects the liver from the lipotoxicity of SFAs [23] . Similar to the TM6SF2 knock-down cells, the hepatic PUFA levels of NASH patients were found to be low and the degree of PUFA reduction was reported to correlate with disease severity [24] . In addition, a variant of FA desaturase 1 (FADS1, Δ-5 desaturase), impairing the insertion of the last double bond when producing AA, has been associated with hepatic lipid accumulation [25] . Moreover, cells and mice deficient in lysophosphatidylcholine acyltransferase 3 (LPCAT3) had reduced levels of AA in their membrane phospholipids, PCs in particular, resulting in defective lipoprotein secretion [9, 26] . Thus aberrations of different proteins modifying or transferring FAs may drive the hepatic lipid accumulation.
The hepatocyte TM6SF2 protein has been localized to the ER and the Golgi apparatus [7, 8] , key organelles of the secretory pathway responsible for the assembly and secretion of VLDL [27, 28] . It is thus plausible that this gene product may modify the lipid composition of the secretory pathway membranes in a manner that promotes their compatibility with lipoprotein production. Thus the reduction of PCs with AA in our TM6SF2 knock-down cells is an especially interesting finding and may represent a key to the observed cellular neutral lipid accumulation. In mice, a similar reduction of AA in membrane phospholipids due to LPCAT3 deficiency caused a marked reduction of plasma VLDL-TAGs with concomitant hepatic steatosis [26] , a phenotype reminiscent of that observed in TM6SF2 knock-out mice [7] . Consistent with the study of Smagris et al. [7] , we also observed a reduction in the size distribution of lipoprotein-like particles secreted by the TM6SF2 knock-down cells, while production of apoB100 was not defective. Besides impaired lipoprotein secretion, the increased lipid content of liver tissue or cultured hepatocytes upon TM6SF2 knock-down or knock-out [3, 5, 7, 8] may in principle reflect enhanced hepatic FA uptake or de novo lipogenesis, reduced mitochondrial oxidation of FAs, or a defect of glucose metabolism and storage as glycogen. We observed in the TM6SF2 knock-down hepatocytes enhanced de novo lipogenesis and reduced FA oxidation. However, no significant alteration of glucose uptake or glycogen synthesis was detected (Fig. S2) , pointing to a primary function of TM6SF2 in lipid metabolism. Labeling/chase of lipids with [
13 C]glycerol revealed both enhanced lipid synthesis and turnover in the TM6SF2 knock-down cells. If the balance of these counteracting homeostatic distortions is biased towards increased synthesis, as indicated by the enhanced de novo lipogenesis observed, this could be one plausible cause of the lipid accumulation observed in the TM6SF2 depleted cells. On the other hand, the fact that also the lipid turnover was increased in the TM6SF2 knock-down cells may explain why the TAG accumulation in our model was not dramatic. The reason for the enhanced dynamics of lipid synthesis/turnover is so far unknown. One possible mechanistic explanation to the increased de novo lipogenesis is ER stress caused by TAG accumulation. TM6SF2 deficiency has been reported to result in ER stress [29] , which is known to induce several signaling pathways upregulating hepatic lipogenesis [30] . One is also tempted to speculate that a distortion of the FA composition of phospholipids (i.e. reduction of PUFAs, AA in particular), may trigger a futile cellular response aimed at maintaining an optimal composition of membrane lipids via enhanced phospholipid synthesis, at the end manifested in the excess of storage lipids as well. In addition to TM6SF2, deficient variants of PNPLA3, MBOAT7 and MBOAT5, which recently were implicated in acyl-chain remodeling of lipids, also induce fatty liver [26, 31, 32] . Thus, a possible role of TM6SF2 in incorporating AA and other PUFAs into membrane phospholipids should be studied further. Impaired FA oxidation and ultrastructural changes in mitochondria have been reported as causes of mitochondrial dysfunction in NAFLD [33, 34] . Therefore, we considered mitochondrial dysfunction as one tentative reason for the lipid accumulation in the TM6SF2 silenced cells. The present observations indeed suggest impaired mitochondrial FA oxidation in these cells. Thus, besides defective TAG secretion and a tentative dysbalance in lipid synthesis/turnover, reduced mitochondrial FA oxidation may be a putative cause of the cellular accumulation of TAGs, CEs, PCs and PEs in the present cell model. Of note, only hepatic TAG and CE but not phospholipid accumulation was previously detected in the TM6SF2 knock-out mice [7] , reflecting an obvious difference between the in vivo and in vitro models or a species difference. The mechanism through which TM6SF2 deficiency might impair mitochondrial function remains subject of future study. In addition, any direct mechanistic link between deficient mitochondrial FA oxidation and enhanced de novo lipogenesis cannot yet be proposed. However, a similar situation was observed in hepatocytes from mice deficient in BNip3 [35] . In those cells, impaired mitochondrial β-oxidation was associated with de novo lipogenesis utilizing glucosederived acetyl-CoA.
While the TAGs and CEs stored in cellular lipid droplets are the frequent response for improved lipogenesis or impaired utilization of lipids, the increased absolute quantities of cellular PCs and PEs found in the TM6SF2 knock-down cells formed an intriguing question. To obtain clues of the fate of these lipids, we carried out transmission EM, which revealed a markedly elevated volume of lysosomal compartments in the TM6SF2 knock-down cells. EM observation of TM6SF2-deficient hepatocytes or liver tissue has not been reported previously. Thus, this observation is novel. It may reflect a homeostatic response triggered in order to hydrolyze an excess of membranes that harbor the accumulating phospholipids. However, the amplification of lysosomes may equally well represent a cellular metabolic adaptation unrelated to the cellular phospholipid excess.
Together with human studies such as that of Luukkonen et al. [36] on the role of hepatic ceramides in NAFLD, our work supports a lipocentric view to liver disease. One can envision that subjects carrying variants of genes such as TM6SF2 or MBOAT7 [3, 32] might benefit from dietary supplementation with PUFAs. On the other hand, preventing CVD by depressing TM6SF2 function [5] might lead to a risk of developing liver disease; therefore, such therapeutic strategies should be considered with caution. TM6SF2 knock-down in human HuH7 hepatoma cells resulted in the enrichment of SFAs/MUFAs in several lipid classes, depletion of PCs with AA, reduced mitochondrial FA oxidation and amplification of late endosomal/lysosomal membrane compartment. Under normal conditions, a dynamic PUFA-enriched ER membrane domain allows the efficient synthesis of apoB-lipoprotein particles, and hepatocellular lipid homeostasis is maintained. Upon TM6SF2 depletion, phospholipids with SFAs and MUFAs accumulate and PUFAs are reduced, resulting in a defect of assembly of apoB lipoproteins with a normal size and lipid composition, associated with cellular neutral lipid accumulation, reduced FA oxidation and an enlarged lysosomal compartment (see Graphical Abstract). The mitochondrial FA oxidation defect could be due to (i) an unoptimal composition of the mitochondrial membranes, (ii) altered ER membrane structure decreasing the size of the secreted lipid particles and possibly impairing the FA flux to mitochondria, and finally (iii) altered structure of the ER membranes disturbing the ER-mitochondial contacts and thereby the flux of FA and also importantly the flux of Ca 2 + between the organelles [37] . Further functional studies are warranted to distinguish between the mechanisms hypothesized above. To conclude, the present observations provide novel clues to the function of TM6SF2 and the mechanism(s) by which the deficiency of the protein disturbs hepatic lipoprotein mediated TAG secretion. Specifically they suggest that the impaired secretion is associated with distorted dynamics of membrane phospholipid synthesis/degradation affected by the unoptimal phospholipid FA composition. 
